Sotac Pharmaceuticals Ltd - Research Center
Group () BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | |
|---|---|---|
| Sales | 33.11 | 30.75 |
| Operating profit | 4.95 | 5.07 |
| Interest | 0.54 | 0.42 |
| Gross profit | 4.93 | 4.76 |
| EPS (Rs) | 2.60 | 13.44 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | |
|---|---|---|
| Other income | 0.52 | 0.11 |
| Stock adjustment | 0.68 | -0.29 |
| Raw material | 20.06 | 20.75 |
| Power and fuel | - | - |
| Employee expenses | 1.44 | 1.46 |
| Excise | - | - |
| Admin and selling expenses | - | - |
| Research and development expenses | - | - |
| Expenses capitalised | - | - |
| Other expenses | 5.98 | 3.75 |
| Provisions made | - | - |
| Depreciation | 1.10 | 0.74 |
| Taxation | 0.96 | 0.93 |
| Net profit / loss | 2.88 | 3.09 |
| Extra ordinary item | - | - |
| Prior year adjustments | - | - |
| Equity capital | 11.05 | 2.30 |
| Equity dividend rate | - | - |
| Agg.of non-prom. shares (Lacs) | - | - |
| Agg.of non promotoholding (%) | - | - |
| OPM (%) | 14.95 | 16.49 |
| GPM (%) | 14.67 | 15.42 |
| NPM (%) | 8.55 | 10.02 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis